Celularity (CELUW) Minority Interest (2019 - 2020)
Celularity (CELUW) reported Minority Interest of $209.1 million for Q4 2020, down 19.06% year-over-year from $258.4 million in Q1 2020, and down 24.34% quarter-over-quarter from $276.4 million in Q3 2020.
Celularity (CELUW) Minority Interest (2019 - 2020) Analysis & Trends
Celularity (CELUW) has 2 years of Minority Interest data on file, last reported at $209.1 million in Q4 2020.
- Minority Interest for Q4 2020 came in at $209.1 million, down 19.06% year-over-year; the trailing twelve-month figure through Dec 2020 was $209.1 million (down 19.06% YoY), and the FY2020 annual result was $209.1 million, down 19.06% from the prior year.
- Minority Interest retreated to $209.1 million in Q4 2020 per CELUW's latest filing, from $276.4 million in the prior quarter.
- Over five years, Minority Interest peaked at $276.6 million in Q1 2020 and troughed at $209.1 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Celularity | - | - | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 209.13 Mn |
| Sep 30, 2020 | 276.41 Mn |
| Jun 30, 2020 | 276.44 Mn |
| Mar 31, 2020 | 276.59 Mn |
| Dec 31, 2019 | 258.39 Mn |
| Sep 30, 2019 | 274.81 Mn |
| Jun 30, 2019 | 273.69 Mn |